Literature DB >> 12775105

Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis.

Vincenzo Ficarra1, Guido Martignoni, Nicola Maffei, Maria Angela Cerruto, Giacomo Novara, Stefano Cavalleri, Walter Artibani.   

Abstract

OBJECTIVES: To evaluate the predictive role of primary tumor histopathological features in predicting inguinal lymph nodes involvement in patients with penile squamous cell carcinoma.
MATERIAL AND METHODS: We retrospectively analysed pathological records from 30 consecutive patients who underwent penectomy for invasive squamous cell carcinoma of the penis. All histological specimens were reviewed by the same pathologist. We considered the following histological parameters: histological grading, growth pattern, deph invasion, tumour thickness, nuclear grading, poorly differentiated cancer rate, vascular and lymphatic embolization, eosinophilic and mononuclear infiltration and pathological stage.
RESULTS: Lymph nodes involvement occurred in 5 patients who underwent 'early' lymphadenectomy and in other 4 ones during oncological surveillance. Lymph nodes metastasis resulted significantly correlated with histological grading (p = 0.005), lymphatic (p = 0.005) and venous (p = 0.02) embolization, corpora cavernosa (p = 0.03) and urethra (p = 0.03) infiltration. Histological grading and lymphatic embolization were independent predictive variables of lymph nodes involvement (p = 0.02).
CONCLUSIONS: The histological grading and lymphatic embolization have to be considered as important parameters to select patients with penile squamous cell carcinoma to undergo an 'early' lymphadenectomy.

Entities:  

Mesh:

Year:  2002        PMID: 12775105     DOI: 10.1023/a:1023243102230

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  21 in total

Review 1.  Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection.

Authors:  S Horenblas
Journal:  BJU Int       Date:  2001-09       Impact factor: 5.588

Review 2.  Squamous cell carcinoma of the penis.

Authors:  G Schoeneich; F G Perabo; S C Müller
Journal:  Andrologia       Date:  1999       Impact factor: 2.775

3.  Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Authors:  A L Bezerra; A Lopes; G H Santiago; K C Ribeiro; M R Latorre; L L Villa
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

4.  Proceedings: Carcinoma of the penis.

Authors:  J B de Kernion; P Tynberg; L Persky; J P Fegen
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

5.  Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy.

Authors:  A Lopes; G S Hidalgo; L P Kowalski; H Torloni; B M Rossi; F P Fonseca
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

6.  Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.

Authors:  D Theodorescu; P Russo; Z F Zhang; C Morash; W R Fair
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

7.  Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system.

Authors:  S Horenblas; H van Tinteren
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

8.  Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion.

Authors:  W S McDougal
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

9.  Treatment of carcinoma of the penis: the case for primary lymphadenectomy.

Authors:  W S McDougal; F K Kirchner; R H Edwards; L T Killion
Journal:  J Urol       Date:  1986-07       Impact factor: 7.450

10.  Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma: assessment of prognostic significance.

Authors:  M C Hall; J S Sanders; F Vuitch; E Ramirez; C A Pettaway
Journal:  Urology       Date:  1998-07       Impact factor: 2.649

View more
  8 in total

Review 1.  [The significance of inguinal lymphadenectomy in carcinoma of the penis].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 2.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 3.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 4.  [Intraoperative frozen section diagnosis of the genitourinary tract].

Authors:  S Bertz; B J Schmitz-Dräger; C Protzel; A Hartmann
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

Review 5.  [Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit].

Authors:  H Borchers; G Jakse
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

6.  The expression of metaloproteinases-2 and -9 is different according to the patterns of growth and invasion in squamous cell carcinoma of the penis.

Authors:  Fernando A Soares; Isabela Werneck da Cunha; Gustavo Cardoso Guimarães; Sueli Nonogaki; Rodrigo Sousa Madeira Campos; Ademar Lopes
Journal:  Virchows Arch       Date:  2006-10-27       Impact factor: 4.064

Review 7.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

8.  Tumor histologic grade is the most important prognostic factor in patients with penile cancer and clinically negative lymph nodes not submitted to regional lymphadenectomy.

Authors:  Giuliano Amorim Aita; Stênio de Cássio Zequi; Walter Henriques da Costa; Gustavo Cardoso Guimarães; Fernando Augusto Soares; Thais Safranov Giuliangelis
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.